# Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients

> **NCT06948357** · PHASE2 · RECRUITING · sponsor: **Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.** · enrollment: 119 (estimated)

## Conditions studied

- Presbyopia

## Interventions

- **DRUG:** BRIMOCHOL PF eye drops; CARBACHOL PF eye drops; Brimonidine eye drops; Placebo

## Key facts

- **NCT ID:** NCT06948357
- **Lead sponsor:** Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-24
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 119 (ESTIMATED)
- **Last updated:** 2025-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06948357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06948357, "Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06948357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*